Equity Overview
Price & Market Data
Price: $2.60
Daily Change: -$0.05 / 1.92%
Range: $2.55 - $2.70
Market Cap: $35,621,040
Volume: 108,073
Performance Metrics
1 Week: -10.03%
1 Month: -45.15%
3 Months: -54.06%
6 Months: -86.19%
1 Year: -84.48%
YTD: -69.77%
Company Details
Employees: 46
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3 kinase alpha harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company is headquartered in Boulder, Colorado.